Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|January 19, 2015
6,6-Fused heterocyclic ureas as highly potent TRPV1 antagonistsWei Sun, Hyo-Shin Kim, Sunho Lee, et al.European Journal of Medicinal Chemistry|February 10, 2015
Pyridine C-region analogs of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonistsHyungChul Ryu, Sejin Seo, Jee-Young Lee, et al.Bioorganic & Medicinal Chemistry|September 17, 2013
TRPV1 antagonist with high analgesic efficacy: 2-Thio pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamidesTae-Hwan Ha, Hyungchul Ryu, Sung-Eun Kim, et al.Bioorganic & Medicinal Chemistry Letters|May 5, 2015
α-Substituted 2-(3-fluoro-4-methylsulfonamidophenyl)acetamides as potent TRPV1 antagonistsPhuong-Thao Tran, Ho Shin Kim, Jihyae Ann, et al.Bioorganic & Medicinal Chemistry Letters|July 17, 2021
2-(Halogenated Phenyl) acetamides and propanamides as potent TRPV1 antagonistsJin Mi Kang, Sun Ok Kwon, Jihyae Ann, et al.Plos Neglected Tropical Diseases|May 3, 2014
Enhanced passive bat rabies surveillance in indigenous bat species from Germany--a retrospective studyJuliane Schatz, Conrad Martin Freuling, Ernst Auer, et al.Bioorganic & Medicinal Chemistry Letters|June 21, 2014
2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonistsHyungChul Ryu, Sejin Seo, Seong-Hee Cho, et al.Bioorganic & Medicinal Chemistry Letters|July 12, 2014
2-Aryl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonistsHyungChul Ryu, Sejin Seo, Myeong Seop Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)Wilfried Ernst Erich Eberhardt, Christoph Pöttgen, Thomas Christoph Gauler, et al.Journal of Cancer Research and Clinical Oncology|December 22, 2015
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patientsJens Köhler, Martin Schuler, Thomas Christoph Gauler, et al.Pageof 8